C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 493/04 (2006.01) A61K 31/34 (2006.01) A61K 31/36 (2006.01) A61K 31/365 (2006.01) A61P 5/06 (2006.01) A61P 9/10 (2006.01) A61P 17/06 (2006.01) A61P 35/00 (2006.01) C07D 317/48 (2006.01) C07D 317/54 (2006.01) C07D 317/70 (2006.01)
Patent
CA 2455328
The invention refers to new compounds and the use thereof as well as the use of known cyclolignans having a trans configuration of the lactone ring as inhibitors of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, especially cancer. Especially deoxypodophyllotoxin can be used for treatment of leukemia in humans.
L'invention concerne de nouveaux composés et leur utilisation, ainsi que l'utilisation de cyclolignans connus présentant une position trans du noyau de lactone comme inhibiteurs du récepteur du facteur-1 de croissance semblable à l'insuline. Lesdits composés peuvent servir dans le traitement de maladies dépendant d'IGF-1R, notamment les cancers. En particulier, on peut utiliser la déoxypodo-phyllotoxine dans le traitement de la leucémie chez les humains.
Axelson Magnus
Larsson Olle
Axelar Ab
Fetherstonhaugh & Co.
LandOfFree
New use of cyclolignans and new cyclolignans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New use of cyclolignans and new cyclolignans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New use of cyclolignans and new cyclolignans will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1711437